IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Northpond Ventures, LLC

Q3 2022 Holdings

Filed 2022-11-14 | 5 holdings | $6.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Candel Therapeutics Inc(CADL)COM137404109$6.1M1,935,21597.8%
Dice Therapeutics IncCOM23345J104$66.8K3,292,8711.1%
Vigil Neuroscience Inc(VIGL)COM92673K108$38.4K4,214,4980.6%
Codex DNA IncCOM192003101$16.3K9,844,1300.3%
Isoplexis CorpCOM465005106$15.2K8,808,5310.2%